DR. MICHAEL WILLIAM DRAPER, M.D.
Hospitals at Woods Bay Pl, Carmel, IN
License number
Indiana 01033641A
Category
Hospitals
Type
General Acute Care Hospital
Address
Address
12192 Woods Bay Pl, Carmel, IN 46033
Phone
(317) 844-1672
Professional information
Methods Of Inhibiting Uterine Fibrosis
US Patent:
5457116, Oct 10, 1995
Filed:
Oct 15, 1993
Appl. No.:
8/138642
Inventors:
Larry J. Black - Indianapolis IN
George J. Cullinan - Trafalgar IN
Michael W. Draper - Carmel IN
Charles D. Jones - Indianapolis IN
David E. Seyler - Greenfield IN
George J. Cullinan - Trafalgar IN
Michael W. Draper - Carmel IN
Charles D. Jones - Indianapolis IN
David E. Seyler - Greenfield IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31445, A61K 3140, A61K 3138
US Classification:
514324
Abstract:
A method of inhibiting uterine fibrosis comprising administering to a human or other mammal in need of treatment an effective amount of a compound having the formula ##STR1## Wherein R. sup. 1 and R. sup. 3 are independently hydrogen, ##STR2## wherein Ar is optionally substituted phenyl; wherein R. sup. 2 is selected from the group consisting of pyrrolidino and piperidino, a pharmaceutically acceptable salt or solvate thereof.
Methods Of Use For Inhibiting Bone Loss And Lowering Serum Cholesterol
US Patent:
5641790, Jun 24, 1997
Filed:
Apr 14, 1995
Appl. No.:
8/422417
Inventors:
Michael W. Draper - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3144, A61K 3140
US Classification:
514333
Abstract:
A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
Methods Of Use For Inhibiting Bone Loss And Lowering Serum Cholesterol
US Patent:
5610168, Mar 11, 1997
Filed:
Apr 14, 1995
Appl. No.:
8/422289
Inventors:
Michael W. Draper - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3144, A61K 3140, A61K 3706
US Classification:
514333
Abstract:
A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
Methods For Inhibiting Endometriosis
US Patent:
5461065, Oct 24, 1995
Filed:
Oct 15, 1993
Appl. No.:
8/138643
Inventors:
Larry J. Black - Indianapolis IN
George J. Cullinan - Trafalgar IN
Michael W. Draper - Carmel IN
Charles D. Jones - Indianapolis IN
David E. Seyler - Greenfield IN
George J. Cullinan - Trafalgar IN
Michael W. Draper - Carmel IN
Charles D. Jones - Indianapolis IN
David E. Seyler - Greenfield IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31445, A61K 3140, A61K 3138
US Classification:
514324
Abstract:
A method of inhibiting endometriosis comprising administering to a human in need of treatment an effective amount of a compound having the formula ##STR1## Wherein R. sup. 1 and R. sup. 3 are independently hydrogen, --CH. sub. 3, ##STR2## wherein Ar is optionally substituted phenyl;
R. sup. 2 is selected from the group consisting of pyrrolidine and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Methods Of Use For Inhibiting Bone Loss And Lowering Serum Cholesterol
US Patent:
5478847, Dec 26, 1995
Filed:
Mar 2, 1994
Appl. No.:
8/205012
Inventors:
Michael W. Draper - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3144, A61K 3140, A61K 3706
US Classification:
514333
Abstract:
A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
Methods Of Use For Inhibiting Bone Loss And Lowering Serum Cholesterol
US Patent:
RE39050, Mar 28, 2006
Filed:
Feb 27, 2003
Appl. No.:
10/375274
Inventors:
Michael W. Draper - Carmel IN, US
Larry J. Black - Franklin IN, US
Larry J. Black - Franklin IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A01N 43/12
US Classification:
514443
Abstract:
A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula
or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompassed by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
Pharmaceutical Unit Dosage Formulations
US Patent:
5747510, May 5, 1998
Filed:
Jan 27, 1997
Appl. No.:
8/788984
Inventors:
Michael W. Draper - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3144, C07D40900
US Classification:
514333
Abstract:
A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
Methods For Inhibiting Endometriosis
US Patent:
5693656, Dec 2, 1997
Filed:
Apr 14, 1995
Appl. No.:
8/422387
Inventors:
Larry J. Black - Indianapolis IN
George J. Cullinan - Trafalgar IN
Michael W. Draper - Carmel IN
Charles D. Jones - Indianapolis IN
David E. Seyler - Greenfield IN
George J. Cullinan - Trafalgar IN
Michael W. Draper - Carmel IN
Charles D. Jones - Indianapolis IN
David E. Seyler - Greenfield IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31445, A61K 3140, A61K 3138
US Classification:
514324
Abstract:
A method of inhibiting endometriosis comprising administering to a human in need of treatment an effective amount of a compound having the formula ##STR1## Wherein R. sup. 1 and R. sup. 3 are independently hydrogen, --CH. sub. 3, ##STR2## wherein Ar is optionally substituted phenyl; R. sup. 2 is selected from the group consisting of pyrrolidine and piperidino; or a pharmaceutically acceptable salt of solvate thereof.